Scienture Holdings (SCNX) Non-Current Deferred Tax Liability (2024 - 2026)
Scienture Holdings' (SCNX) quarterly Non-Current Deferred Tax Liability came in at $11.0 million in Q2 2026, down 18.39% year-over-year from $13.5 million in Q2 2025, and little changed quarter-over-quarter from $11.0 million in Q1 2026.
Analysis
Scienture Holdings (SCNX) Non-Current Deferred Tax Liability (2024 - 2026) Analysis & Trends
Scienture Holdings has disclosed Non-Current Deferred Tax Liability across 3 years of filings, most recently posting $11.0 million for Q2 2026.
- In Q2 2026, Non-Current Deferred Tax Liability fell 18.39% year-over-year to $11.0 million; the TTM figure through Jun 2026 stood at $11.0 million (down 18.39% YoY), while the FY2025 annual figure was $11.0 million, down 18.39% from the prior year.
- Non-Current Deferred Tax Liability came in at $11.0 million for Q2 2026 at Scienture Holdings, roughly flat from $11.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $13.5 million in Q4 2024 to a low of $11.0 million in Q4 2025.
- Average Non-Current Deferred Tax Liability over 3 years is $12.3 million, with a median of $12.3 million recorded in 2024.
- The largest YoY upside for Non-Current Deferred Tax Liability was 18.39% in 2025 against a maximum downside of 18.39% in 2025.
- Over 3 years, Non-Current Deferred Tax Liability stood at $13.5 million in 2024, then fell by 18.39% to $11.0 million in 2025, then changed by 0.0% to $11.0 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $11.0 million in Q2 2026, $11.0 million in Q1 2026, and $11.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.04 Mn |
| Mar 31, 2026 | 11.04 Mn |
| Dec 31, 2025 | 11.04 Mn |
| Jun 30, 2025 | 13.52 Mn |
| Mar 31, 2025 | 13.52 Mn |
| Dec 31, 2024 | 13.52 Mn |